|
|
Volumn 8, Issue 2, 1997, Pages 207-217
|
|
Acute therapeutic intervention: Antithrombotic and antiplatelet- aggregating drugs
a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
HEPARIN DERIVATIVE;
HEPARINOID;
LOW MOLECULAR WEIGHT HEPARIN;
FIBRINOLYTIC AGENT;
MONOCLONAL ANTIBODY;
ANTICOAGULANT THERAPY;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
DRUG RESEARCH;
HEPARINIZATION;
HUMAN;
PRIORITY JOURNAL;
PROPHYLAXIS;
REVIEW;
STROKE;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOSIS PREVENTION;
BRAIN ISCHEMIA;
ANTIBODIES, MONOCLONAL;
ASPIRIN;
BRAIN ISCHEMIA;
CLINICAL TRIALS;
FIBRINOLYTIC AGENTS;
HEPARIN;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HEPARINOIDS;
HIRUDIN THERAPY;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
|
|
EID: 0031114804
PISSN: 10423680
EISSN: None
Source Type: Journal
DOI: 10.1016/s1042-3680(18)30323-1 Document Type: Review |
|
Times cited : (4)
|
|
References (95)
|